{"database": "lobbying", "table": "lobbying_activities", "rows": [[2503881, "25bcf25e-e2fc-47a9-afb4-e1074837f16b", "Q3", "HOLLAND & KNIGHT LLP", 18466, "VIATRIS INC", 2020, "third_quarter", "PHA", "Drug shortages, formulary tiering, National Defense Authorization Act (NDAA), biosimilar uptake, Medicare generics penalty, generic drugs, supply chain.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-10-05T10:52:24.070000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2503881"], "units": {}, "query_ms": 35.54532304406166, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}